Late complications of radiation therapy for breast cancer: evolution in techniques and risk over time - PubMed (original) (raw)

Review

Late complications of radiation therapy for breast cancer: evolution in techniques and risk over time

Zachary Brownlee et al. Gland Surg. 2018 Aug.

Abstract

Radiation therapy in combination with surgery, chemotherapy, and endocrine therapy as indicated, has led to excellent local and distant control of early stage breast cancers. With the majority of these patients surviving long term, mitigating the probability and severity of late toxicities is vital. Radiation to the breast, with or without additional fields for nodal coverage, has the potential to negatively impact long term cosmetic outcome of the treated breast as well as cause rare, but severe, complications due to incidental dosage to the heart, lungs and contralateral breast. The long-term clinical side-effects of breast radiation have been studied extensively. This review aims to discuss the risk of developing late complications following breast radiation and how modern techniques can be used to diminish these risks.

Keywords: Radiation; breast cancer; late toxicity.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Similar articles

• Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
  Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Wazer DE, et al. Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):489-95. doi: 10.1016/j.ijrobp.2005.06.028. Epub 2005 Oct 24. Int J Radiat Oncol Biol Phys. 2006. PMID: 16246495
• [Local tumor control and cosmetic outcome following breast-conserving surgery and radiation up to a total dose of 56 Gy without boost in breast cancer].
  Bayerl A, Frank D, Lenz A, Höss C, Lukas P, Feldmann HJ, Molls M. Bayerl A, et al. Strahlenther Onkol. 2001 Jan;177(1):25-32. doi: 10.1007/pl00002354. Strahlenther Onkol. 2001. PMID: 11200109 German.
• Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
  Benitez PR, Chen PY, Vicini FA, Wallace M, Kestin L, Edmundson G, Gustafson G, Martinez A. Benitez PR, et al. Am J Surg. 2004 Oct;188(4):355-64. doi: 10.1016/j.amjsurg.2004.06.027. Am J Surg. 2004. PMID: 15474426
• [Individual modification of the dose, volume and fractionation of breast radiotherapy].
  Bourgier C, Lemanski C, Draghici R, Castan F, Fenoglietto P, Bons F, Farcy-Jacquet MP, Brengues M, Gourgou S, Ozsahin M, Azria D. Bourgier C, et al. Cancer Radiother. 2019 Oct;23(6-7):778-783. doi: 10.1016/j.canrad.2019.06.004. Epub 2019 Aug 1. Cancer Radiother. 2019. PMID: 31378461 Review. French.
• Adult life after surviving lymphoma in childhood.
  von der Weid NX. von der Weid NX. Support Care Cancer. 2008 Apr;16(4):339-45. doi: 10.1007/s00520-007-0369-x. Epub 2008 Jan 15. Support Care Cancer. 2008. PMID: 18196290 Review.

Cited by

• Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance.
  Yazarlou F, Martinez I, Lipovich L. Yazarlou F, et al. Front Oncol. 2024 Sep 13;14:1437542. doi: 10.3389/fonc.2024.1437542. eCollection 2024. Front Oncol. 2024. PMID: 39346726 Free PMC article. Review.
• Meta-Analysis of Xihuang Pill Efficacy When Combined with Chemotherapy for Treatment of Breast Cancer.
  Mao D, Feng L, Huang S, Zhang S, Peng W, Zhang S. Mao D, et al. Evid Based Complement Alternat Med. 2019 Mar 12;2019:3502460. doi: 10.1155/2019/3502460. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 30992708 Free PMC article. Review.
• Current status of pre- and retropectoral breast reconstructions worldwide: a narrative review.
  Gunnarsson GL, Salzberg CA. Gunnarsson GL, et al. Gland Surg. 2024 Jul 30;13(7):1305-1314. doi: 10.21037/gs-24-13. Epub 2024 Jul 24. Gland Surg. 2024. PMID: 39175699 Free PMC article. Review.
• Activated ERK Signaling Is One of the Major Hub Signals Related to the Acquisition of Radiotherapy-Resistant MDA-MB-231 Breast Cancer Cells.
  Paramanantham A, Jung EJ, Go SI, Jeong BK, Jung JM, Hong SC, Kim GS, Lee WS. Paramanantham A, et al. Int J Mol Sci. 2021 May 6;22(9):4940. doi: 10.3390/ijms22094940. Int J Mol Sci. 2021. PMID: 34066541 Free PMC article.
• Proton Reirradiation for High-Risk Recurrent or New Primary Breast Cancer.
  Chakraborty MA, Khan AJ, Cahlon O, Xu AJ, Braunstein LZ, Powell SN, Choi JI. Chakraborty MA, et al. Cancers (Basel). 2023 Dec 6;15(24):5722. doi: 10.3390/cancers15245722. Cancers (Basel). 2023. PMID: 38136268 Free PMC article. Review.

References

1. 1. Taylor ME, Perez CA, Halverson KJ, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 1995;31:753-64. 10.1016/0360-3016(94)00480-3 - DOI - PubMed
2. 1. Whelan TJ, Pignol JP, Levine MN, et al. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. NEJM 2010;362:513-20. 10.1056/NEJMoa0906260 - DOI - PubMed
3. 1. Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a Higher Radiation dose on Local Control andn Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized boost Versus No Boost EORTC 2881-10882 Trial. J Clin Oncol 2007;25:3259-65. 10.1200/JCO.2007.11.4991 - DOI - PubMed
4. 1. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy Boost in the Conservative Treatment of Early Breast Cancer: Results of a Randomized Clinical Trial in Lyon, France. J Clin Oncol 1997;15:963-8. 10.1200/JCO.1997.15.3.963 - DOI - PubMed
5. 1. Jhaveri JD, Rush SC, Kostroff K, et al. Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction. Int J Radiat Oncol Biol Phys 2008;72:859-65. 10.1016/j.ijrobp.2008.01.055 - DOI - PubMed

Publication types

LinkOut - more resources

• Full Text Sources

  • AME Publishing Company
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • scite Smart Citations